Clive Prestidge

Prof Clive Prestidge

Professor

School of Pharmacy and Biomedical Science

College of Health

Available For Media Comment.

Professor of Pharmaceutical Science
Clive Prestidge is currently a Professor within Clinical and Health Science, a lead researcher within UniSA's Cancer Research Institute and head of the Nanostructure and Drug Delivery research group.
Clive is the author of over 250 refereed international journal articles, textbook chapters and conference papers and over 100 major project reports to industry. He has supervised more than 35 PhD, 10 MSc and 30 Honours students and has taken a leadership role in a number of major collaborative projects in association with national and international industries, the ARC, and University researchers from Australia and overseas. Prof Prestidge has attracted competitive research grants worth more than $15M from government and industry sources.
Clive was the founder of Ceridia Pty Ltd, a clinical stage biopharmaceutical company established to commercial the the Lipoceramic drug delivery technology he invented.
The Prestidge research group is focused on Drug delivery, Nanomedicine and BioPharmaceutical Engineering. Its Primary Mission is to: (1) Engineer novel particle based biomaterials with specific biological activity and their application to solve biopharmaceutical challenges. (2) Determine mechanisms for bioactivity through advanced biophysical analysis (3) Develop drug delivery solutions to address unmet clinical needs. Some of our Grand Challenges are to: (1) Deliver Challenging Therapeutic Molecules – For Better Medicines (2) Eradicate Bacterial Biofilms (3) Optimise Biotech and Pharmaceutical Processing and Manufacture

  • Drug delivery systems
  • Pharmaceutical formulation and delivery
  • Nanomedicine
  • Biointerfaces

The Prestidge research group is focused on Nanomedicine and BioPharmaceutical Engineering. Its Primary Mission is to: (1) Engineer novel particle based biomaterials with specific biological activity and their application to solve biopharmaceutical challenges. (2) Determine mechanisms for bioactivity through advanced biophysical analysis (3) Develop drug delivery solutions to address unmet clinical needs. Some of our Grand Challenges are to: (1) Deliver Challenging Therapeutic Molecules – For Better Medicines (2) Eradicate Bacterial Biofilms (3) Optimise Biotech and Pharmaceutical Processing and Manufacture

Year Citation
2025 Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., . . . Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Pt 1), 15 pages.
DOI
2025 Hosseini-Kharat, M., Bremmell, K. E., Grubor-Bauk, B., & Prestidge, C. A. (2025). Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity. Journal of Controlled Release, 378, 170-194.
DOI Scopus14 WoS13 Europe PMC9
2025 Wright, L., Wignall, A., Subramaniam, S., Schultz, H. B., Joyce, P., & Prestidge, C. A. (2025). Enhanced oral absorption and biodistribution to submandibular salivary glands of D-limonene in Sprague Dawley rats via a liquid-lipid formulation approach. International Journal of Pharmaceutics, 670(125179), 125179.
DOI Scopus1 WoS1 Europe PMC1
2025 Hosseini-Kharat, M., Wignall, A., Mekonnen, Z. A., Ung, B. S. -Y., Chereda, B., Bremmell, K. E., . . . Prestidge, C. A. (2025). Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression. Pharmaceutics, 17(4), 454.
DOI Scopus1 WoS1
2025 Taheri, A., Almasri, R., Wignall, A., Feltrin, F., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2025). Enteric coating enhances the Biopharmaceutical performance of a silica-lipid formulation of Abiraterone Acetate. Pharmaceutics, 17(10, article no. 1289), 1-12.
DOI
2025 Arafat, M., Wignall, A., Brewer, K., Song, Y., Albrecht, H., Prestidge, C. A., . . . Blencowe, A. (2025). Comparison of polymer-coated, drug-eluting self-expandable metal stents for the potential treatment of gastrointestinal cancers. Rsc Pharmaceutics, 2(3), 611-623.
DOI
2025 Mahboob, M. B. H., Subramaniam, S., Tait, J. R., Grace, J. L., Elliott, A. G., Floyd, H., . . . Whittaker, M. R. (2025). Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals. Journal of Materials Chemistry B, 13(8), 2776-2795.
DOI
2025 Ahsan, A., Barnes, T. J., Thomas, N., Subramaniam, S., & Prestidge, C. A. (2025). Lipid-based nanocarriers for enhanced gentamicin delivery: a comparative study of liquid crystal nanoparticles and liposomes against Escherichia coli biofilms. Drug Delivery And Translational Research, online(11), 1-22.
DOI
2025 Soltanifar, Y., Rahimi, R., Prestidge, C. A., & Hosseini Kharat, M. (2025). Green synthesis of l-Cysteine-Functionalized rGO-Silver Nanoparticles for enhanced Photocatalytic and Antibacterial applications. Acs Omega, 10(39), 45000-45010.
DOI
2025 Abdelhafez, A., Khabir, Z., Prestidge, C. A., Garcia Bennett, A., & Joyce, P. (2025). Impact of formulation design on the oral bioavailability of omega-3 polyunsaturated fatty acids. Food Research International, 208(116171), 1-16.
DOI
2025 Hosseini Kharat, M., Bremmell, K. E., & Prestidge, C. A. (2025). Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Molecular Therapy Methods and Clinical Development, 33(1, article no. 101436), 1-14.
DOI
2024 Subramaniam, S., Joyce, P., & Prestidge, C. A. (2024). The biomolecule corona mediates pulmonary delivery of nanomedicine. European Journal of Pharmaceutics and Biopharmaceutics, 202(114420), 1-8.
DOI
2024 Aparicio Blanco, J., Vishwakarma, N., Lehr, C. M., Prestidge, C. A., Thomas, N., Roberts, R. J., . . . Melero, A. (2024). Antibiotic resistance and tolerance: What can drug delivery do against this global threat?. Drug Delivery and Translational Research, 14(6), 1725-1734.
DOI
2024 Ahsan, A., Thomas, N., Barnes, T. J., Subramaniam, S., Loh, T. C., Joyce, P., & Prestidge, C. A. (2024). Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics, 16(3, article no. 396), 1-46.
DOI
2024 Subramaniam, S., Joyce, P., Conn, C. E., & Prestidge, C. A. (2024). Cellular uptake and in vitro antibacterial activity of lipid-based nanoantibiotics are influenced by protein corona. Biomaterials Science, 12(13), 3411-3422.
DOI
2024 Iscaro, J., Yu, H., Martinez, N., Subramaniam, S., Joyce, P., Wang, H., . . . Zhai, J. (2024). Lyotropic liquid crystalline phase nanostructure and cholesterol enhance lipid nanoparticle mediated mRNA transfection in macrophages. Advanced Functional Materials, 34(no. 46, article no. 2405286), 1-15.
DOI Scopus11 WoS13
2024 Ariaee, A., Salim, M., Boyd, B. J., Prestidge, C., & Joyce, P. (2024). Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion. Journal of Colloid and Interface Science, 675, 660-669.
DOI
2024 Taheri, A., Almasri, R., Wignall, A., Schultz, H. B., Elz, A. S., Ariaee, A., . . . Prestidge, C. A. (2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges. Drug Delivery and Translational Research, online(11), 3770-3782.
DOI WoS2 Europe PMC1
2024 Meola, T. R., Kamath, S., Elz, A. S., Prestidge, C. A., Wignall, A., & Joyce, P. (2024). Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic. European Journal of Pharmaceutics and Biopharmaceutics, 203, 10 pages.
DOI Scopus2 WoS2 Europe PMC1
2024 Meola, T. R., Elz, A., Wignall, A., Paxton, K., Hunter, A., Ariaee, A., . . . Joyce, P. (2024). Inulin-Lipid Core–Shell Microcapsules Target the Gut Microbiota and Mimic the Pharmaceutical Food Effect for Improved Oral Antipsychotic Delivery. Advanced Functional Materials, 34(40), 12 pages.
DOI Scopus14 WoS14
2024 Ariaee, A., Wardill, H. R., Wignall, A., Prestidge, C. A., & Joyce, P. (2024). Correction: Ariaee et al. The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods 2024, 13, 1039. Foods, 13(24), 4030.
DOI
2024 Cade, S., Prestidge, C., Zhou, X. F., & Bobrovskaya, L. (2024). The effects of a bioavailable curcumin formulation on Alzheimer's disease pathologies: A potential risk for neuroinflammation. Ibrain, 10(4), 391-547.
DOI Scopus1
2024 Ariaee, A., Wardill, H. R., Wignall, A., Elz, A. S., Wright, L., Prestidge, C., & Joyce, P. (2024). Therapeutic Potential of Inulin-Coated MCT Microcapsules in Modulating the Gut Microbiome for Effective Treatment of Diet-Induced Obesity. Advanced Therapeutics, 8(3), 13 pages.
DOI
2024 Joyce, P., Allen, C. J., Alonso, M. J., Ashford, M., Bradbury, M. S., Germain, M., . . . Santos, H. A. (2024). A translational framework to DELIVER nanomedicines to the clinic. Nature Nanotechnology, 19(11), 1597-1611.
DOI Scopus120 WoS110 Europe PMC74
2024 Ariaee, A., Koentgen, S., Wardill, H. R., Hold, G. L., Prestidge, C. A., Armstrong, H. K., & Joyce, P. (2024). Prebiotic selection influencing inflammatory bowel disease treatment outcomes: A review of the preclinical and clinical evidence. eGastroenterology, 2(2), 1-14.
DOI Scopus11 WoS10 Europe PMC6
2024 Feizi, S., Awad, M., Ramezanpour, M., Cooksley, C., Murphy, W., Prestidge, C. A., . . . Vreugde, S. (2024). Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against <i>Mycobacterium abscessus</i> Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.. ACS applied materials & interfaces, 16(51), 70274-70283.
DOI Scopus1 WoS1 Europe PMC1
2024 King, J. J., Chen, K., Evans, C. W., Norret, M., Almasri, R., Pavlos, N. J., . . . Iyer, K. S. (2024). High-resolution visualisation of antisense oligonucleotide release from polymers in cells. Chemical Science, 15(38), 15690-15697.
DOI
2024 Subramaniam, S., Joyce, P., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C. M., & Prestidge, C. A. (2024). Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS Infectious Diseases, 10(2), 337-349.
DOI Scopus6 WoS6 Europe PMC6
2024 Nguyen, T. M., Joyce, P., Ross, D. M., Bremmell, K., Jambhrunkar, M., Wong, S. S., & Prestidge, C. A. (2024). Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics, 16(2), 209-1-209-16.
DOI Scopus7 WoS5 Europe PMC3
2024 Revesz, I. A., Joyce, P., Ebert, L. M., & Prestidge, C. A. (2024). Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy. Clinical and Translational Immunology, 13(2, article no. e1492), 1-16.
DOI Scopus9 WoS9 Europe PMC7
2024 Ariaee, A., Wardill, H. R., Wignall, A., Prestidge, C. A., & Joyce, P. (2024). The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods, 13(7), 1039.
DOI Scopus11 WoS10 Europe PMC9
2023 Awad, M., Barnes, T. J., & Prestidge, C. A. (2023). Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System. Antibiotics, 12(9), 1405.
DOI Scopus3
2023 Awad, M., Kopecki, Z., Barnes, T. J., Wignall, A., Joyce, P., Thomas, N., & Prestidge, C. A. (2023). Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics, 15(2), 1-18.
DOI Scopus6 WoS5 Europe PMC3
2023 Tam, J. S. Y., Coller, J. K., Prestidge, C. A., & Bowen, J. M. (2023). Investigation of TLR4 Antagonists for Prevention of Intestinal Inflammation. Inflammation, 46(1), 103-114.
DOI Scopus12 WoS12 Europe PMC7
2023 Delon, L. C., Faria, M., Jia, Z., Johnston, S., Gibson, R., Prestidge, C. A., & Thierry, B. (2023). Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine-on-Chip Models. Small Methods, 7(1), 1-12.
DOI Scopus12 WoS13 Europe PMC10
2023 Wright, L., Wignall, A., Jõemetsa, S., Joyce, P., & Prestidge, C. A. (2023). A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems. Drug Delivery and Translational Research, 13(4), 1088-1101.
DOI Scopus11 WoS12 Europe PMC10
2023 Nguyen, T. M., Jambhrunkar, M., Wong, S. S., Ross, D. M., Joyce, P., Finnie, J. W., . . . Prestidge, C. A. (2023). Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes.. Molecular pharmaceutics, 20(8), 3937-3946.
DOI Scopus8 WoS7 Europe PMC6
2023 Kamath, S., Stringer, A. M., Prestidge, C. A., & Joyce, P. (2023). Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opinion on Drug Delivery, 20(10), 1315-1331.
DOI Scopus23 WoS22 Europe PMC19
2023 Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., . . . Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International Journal of Pharmaceutics, 648(123614), 123614-1-123614-10.
DOI Scopus31 WoS27 Europe PMC19
2023 Jambhrunkar, M., Maghrebi, S., Doddakyathanahalli, D., Wignall, A., Prestidge, C. A., & Bremmell, K. E. (2023). Mesoporous organosilica nanoparticles to fight intracellular staphylococcal aureus infections in macrophages. Pharmaceutics, 15(4, article no. 1037), 1-12.
DOI WoS4 Europe PMC1
2023 Subramaniam, S., Joyce, P., Donnellan, L., Young, C., Wignall, A., Hoffmann, P., & Prestidge, C. A. (2023). Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles. Journal of Colloid and Interface Science, 641, 36-47.
DOI Scopus32 WoS31 Europe PMC23
2023 Møller, A., Schultz, H. B., Meola, T. R., Joyce, P., Müllertz, A., & Prestidge, C. A. (2023). The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics, 15(1), 14 pages.
DOI Scopus1
2023 Maghrebi, S., Thomas, N., Prestidge, C. A., & Joyce, P. (2023). Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages. Drug Delivery and Translational Research, 13(6), 1716-1729.
DOI
2023 Dai, T., & Prestidge, C. A. (2023). Light and drug delivery-based antimicrobial therapies in the fight against infectious diseases. Advanced Drug Delivery Reviews, 197(114792), 1-2.
DOI
2023 Subramaniam, S., Joyce, P., & Prestidge, C. A. (2023). Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus. International Journal of Pharmaceutics, 639(639, article no. 122927), 1-9.
DOI
2023 Subramaniam, S., Kamath, S., Ariaee, A., Prestidge, C., & Joyce, P. (2023). The impact of common pharmaceutical excipients on the gut microbiota. Expert Opinion on Drug Delivery, 20(10), 1297-1394.
DOI
2023 Hassan, M. M., Romana, B., Mao, G., Kumar, N., Sonvico, F., Thordarson, P., . . . Prestidge, C. A. (2023). Liposome-Micelle-Hybrid (LMH) carriers for controlled co-delivery of 5-FU and paclitaxel as chemotherapeutics. Pharmaceutics, 15(7, article no. 1886), 1-17.
DOI
2023 Taheri, A., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2023). Battle of the milky way: lymphatic targeted drug delivery for pathogen eradication. Journal of Controlled Release, 363, 507-524.
DOI
2022 Almasri, R., Schultz, H. B., Møller, A., Bremmell, K. E., Garcia Bennett, A., Joyce, P., & Prestidge, C. A. (2022). Role of silica intrawall microporosity on abiraterone acetate solubilization and in vivo oral absorption. Molecular Pharmaceutics, 19(4), 1091-1103.
DOI
2022 Chang, P. K. C., Prestidge, C. A., & Bremmell, K. E. (2022). PAMAM versus PEI complexation for siRNA delivery: interaction with model lipid membranes and cellular uptake. Pharmaceutical Research, 39(6), 1151-1163.
DOI
2022 Chen, J., Hanrahan, J. P., McGrath, J., Courtney, M. A., Prestidge, C. A., & Joyce, P. (2022). The anti-obesity effect of porous silica is dependent on pore nanostructure, particle size, and surface chemistry in an in vitro digestion model. Pharmaceutics, 14(9, article no. 1813), 1-16.
DOI
2022 Wang, W., Joyce, P., Bremmell, K., Milne, R., & Prestidge, C. A. (2022). Liposomal 5-fluorouracil polymer complexes facilitate tumor-specific delivery: pharmaco-distribution kinetics using microdialysis. Pharmaceutics, 14(2, article no. 221), 1-16.
DOI Scopus10 WoS8 Europe PMC6
2022 Meola, T. R., Bremmell, K. E., Williams, D. B., Schultz, H. B., & Prestidge, C. A. (2022). Bio-enabling strategies to mitigate the pharmaceutical food effect: A mini review. International Journal of Pharmaceutics, 619(121695), 14 pages.
DOI Scopus7 WoS6 Europe PMC4
2022 Wright, L., Barnes, T. J., Joyce, P., & Prestidge, C. A. (2022). Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics, 14(12), 2659.
DOI Scopus11 WoS10 Europe PMC5
2022 Thorn, C. R., Wignall, A., Kopecki, Z., Kral, A., Prestidge, C. A., & Thomas, N. (2022). Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of Pseudomonas aeruginosa Biofilm Wound Infection. ACS Infectious Diseases, 8(4), 841-854.
DOI Scopus15 WoS15 Europe PMC13
2022 Thorn, C. R., Kopecki, Z., Wignall, A., Kral, A., Prestidge, C. A., & Thomas, N. (2022). Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections. Nanomedicine Nanotechnology Biology and Medicine, 42(102536), 12 pages.
DOI Scopus11 WoS8 Europe PMC8
2022 Tam, J. S. Y., Crame, E. E., Elz, A. S., Coller, J. K., Wignall, A., Prestidge, C. A., & Bowen, J. M. (2022). Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity. Cancer Chemotherapy and Pharmacology, 90(3), 267-278.
DOI Scopus5 WoS4 Europe PMC5
2022 Joyce, P., Wignall, A., Peressin, K., Wright, L., Williams, D. B., & Prestidge, C. A. (2022). Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. International Journal of Pharmaceutics, 612(121382), 121382.
DOI Scopus15 WoS16 Europe PMC9
2022 Awad, M., Barnes, T. J., Thomas, N., Joyce, P., & Prestidge, C. A. (2022). Gallium Protoporphyrin Liquid Crystalline Lipid Nanoparticles: A Third-Generation Photosensitizer against Pseudomonas aeruginosa Biofilms. Pharmaceutics, 14(10), 2124.
DOI Scopus13
2022 Awad, M., Barnes, T. J., Joyce, P., Thomas, N., & Prestidge, C. A. (2022). Liquid crystalline lipid nanoparticle promotes the photodynamic activity of gallium protoporphyrin against S. aureus biofilms. Journal of Photochemistry and Photobiology B: Biology, 232(112474), 112474.
DOI Scopus17 Europe PMC9
2022 Awad, M., Thomas, N., Barnes, T. J., & Prestidge, C. A. (2022). Nanomaterials enabling clinical translation of antimicrobial photodynamic therapy. Journal of Controlled Release, 346, 300-316.
DOI Scopus59 Europe PMC35
2022 Elz, A. S., Trevaskis, N. L., Porter, C. J. H., Bowen, J. M., & Prestidge, C. A. (2022). Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport. Journal of Controlled Release, 341, 676-701.
DOI Scopus44 WoS38 Europe PMC27
2022 Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022). Mechanisms of uptake and transport of particulate formulations in the small intestine. Journal of Controlled Release, 343, 584-599.
DOI Scopus45 WoS39 Europe PMC31
2021 Tam, S. Y., Coller, J. K., Hughes, P. A., Prestidge, C. A., & Bowen, J. M. (2021). Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian Journal of Gastroenterology, 40(1), 5-21.
DOI Scopus66 WoS59 Europe PMC56
2021 Feizi, S., Cooksley, C. M., Bouras, G. S., Prestidge, C. A., Coenye, T., Psaltis, A. J., . . . Vreugde, S. (2021). Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis.. Colloids and surfaces. B, Biointerfaces, 202, 1-10.
DOI Scopus20 WoS21 Europe PMC14
2021 Wright, L., Joyce, P., Barnes, T. J., Lundmark, R., Bergström, C. A. S., Hubert, M., & Prestidge, C. A. (2021). A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics. Journal of Pharmaceutical Sciences, 110(1), 217-227.
DOI Scopus9 WoS11 Europe PMC7
2021 Wright, L., Joyce, P., Barnes, T. J., & Prestidge, C. A. (2021). Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation. ACS Biomaterials Science & Engineering, 9(6), 19 pages.
DOI Scopus23 WoS24 Europe PMC14
2021 Meola, T., Abuhelwa, A. Y., Joyce, P., Clifon, P., & Prestidge, C. (2021). A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants. Drug Delivery and Translational Research, 11(3), 1261-1272.
DOI Scopus34 WoS31 Europe PMC22
2021 Meola, T. R., Joyce, P., Wignall, A., Bremmell, K. E., & Prestidge, C. A. (2021). Harnessing the potential of nanostructured formulations to mimic the food effect of lurasidone. International Journal of Pharmaceutics, 608(121098), 10 pages.
DOI Scopus11 WoS11 Europe PMC7
2021 Arafat, M., Fouladian, P., Wignall, A., Song, Y., Parikh, A., Albrecht, H., . . . Blencowe, A. (2021). Development and in vitro evaluation of 5-fluorouracil-eluting stents for the treatment of colorectal cancer and cancer-related obstruction. Pharmaceutics, 13(1), 1-22.
DOI Scopus23 WoS20 Europe PMC11
2021 Jia, Z., Wignall, A., Prestidge, C., & Thierry, B. (2021). An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer's patches microfold cells. International Journal of Pharmaceutics, 594(120167), 1-7.
DOI WoS12 Europe PMC9
2021 Møller, A., Schultz, H. B., Meola, T. R., Müllertz, A., & Prestidge, C. A. (2021). The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations. European Journal of Pharmaceutical Sciences, 157(article no. 105640), 10 pages.
DOI Scopus9 WoS7 Europe PMC4
2021 Thorn, C. R., Raju, D., Lacdao, I., Gilbert, S., Sivarajah, P., Howell, P. L., . . . Thomas, N. (2021). Protective liquid crystal nanoparticles for targeted delivery of PsIG: a biofilm dispersing enzyme. ACS Infectious Diseases, 7(8), 2102-2115.
DOI Europe PMC26
2021 Thorn, C. R., Thomas, N., Boyd, B. J., & Prestidge, C. A. (2021). Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy. Drug Delivery and Translational Research, 11(4), 1598-1624.
DOI
2021 Thorn, C. R., Howell, P. L., Wozniak, D. J., Prestidge, C. A., & Thomas, N. (2021). Enhancing the therapeutic use of biofilm-dispersing enzymes with smart drug delivery systems. Advanced Drug Delivery Reviews, vol. 179(113916), 1-18.
DOI
2021 Albayaty, Y. N., Thomas, N., Ramírez García, P. D., Davis, T. P., Quinn, J. F., Whittaker, M. R., & Prestidge, C. A. (2021). Polymeric micelles with anti-virulence activity against Candida albicans in a single- and dual-species biofilm. Drug Delivery and Translational Research, 11(4), 1586-1597.
DOI
2021 Jia, Z., Guo, Z., Yang, C. T., Prestidge, C., & Thierry, B. (2021). 'Mucus-on-chip': a new tool to study the dynamic penetration of nanoparticulate drug carriers into mucus. International Journal of Pharmaceutics, 598(120391), 1-9.
DOI Scopus29 Europe PMC19
2021 Thorn, C. R., Carvalho Wodarz, C. D. S., Horstmann, J. C., Lehr, C. M., Prestidge, C. A., & Thomas, N. (2021). Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms. Small, 17(24, article no. 2100531), 1-17.
DOI
2021 Subramaniam, S., Joyce, P., Thomas, N., & Prestidge, C. A. (2021). Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Advanced Drug Delivery Reviews, 177(113948), 1-23.
DOI
2020 Bremmell, K. E., Briskey, D., Meola, T. R., Mallard, A., Prestidge, C. A., & Rao, A. (2020). A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults. European Journal of Nutrition, 59(6), 2729-2737.
DOI Scopus24 WoS22 Europe PMC15
2020 Meola, T. R., Schultz, H. B., Peressin, K. F., & Prestidge, C. A. (2020). Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: the effect of supersaturation and silica geometry. European Journal of Pharmaceutical Sciences, 150(105357), 1-10.
DOI Scopus30 WoS27 Europe PMC16
2020 Schultz, H. B., Meola, T. R., Thomas, N., & Prestidge, C. A. (2020). Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate. International Journal of Pharmaceutics, 577(119069), 1-12.
DOI Scopus53 WoS50 Europe PMC28
2020 Meola, T. R., Paxton, K., Joyce, P., Schultz, H. B., & Prestidge, C. A. (2020). The effect of drug ionization on lipid-based formulations for the oral delivery of anti-psychotics. Admet and Dmpk, 8(4), 437-451.
DOI Scopus9 WoS9 Europe PMC5
2020 Joyce, P., Meola, T. R., Schultz, H. B., & Prestidge, C. A. (2020). Biomaterials that regulate fat digestion for the treatment of obesity. Trends in Food Science and Technology, 100, 235-245.
DOI Scopus23 WoS19
2020 Thorn, C. R., Clulow, A. J., Boyd, B. J., Prestidge, C. A., & Thomas, N. (2020). Bacterial lipase triggers the release of antibiotics from digestible liquid crystal nanoparticles. Journal of Controlled Release, 319, 168-182.
DOI
2020 Maghrebi, S., Joyce, P., Jambhrunkar, M., Thomas, N., & Prestidge, C. A. (2020). Poly(lactic-co-glycolic) acid-lipid hybrid microparticles enhance the intracellular uptake and antibacterial activity of rifampicin. ACS, 12(7), 8030-8039.
DOI
2020 Schultz, H. B., Joyce, P., Thomas, N., & Prestidge, C. A. (2020). Supersaturated-silica lipid hybrids improve in vitro solubilization of abiraterone acetate. Pharmaceutical Research, 37(4, article number. 77), 1.
DOI
2020 Joyce, P., Ulmefors, H., Garcia Bennett, A., & Prestidge, C. A. (2020). Microporosity, pore size, and diffusional path length modulate lipolysis kinetics of triglycerides adsorbed onto SBA-15 mesoporous silica particles. Langmuir, 36(13), 3367-3376.
DOI
2020 Al Bayaty, N., Thomas, N., Ramírez García, P. D., Davis, T. P., Quinn, J. F., Whittaker, M. R., & Prestidge, C. A. (2020). PH-Responsive copolymer micelles to enhance itraconazole efficacy against: Candida albicans biofilms. Journal of Materials Chemistry B, 8(8), 1672-1681.
DOI
2020 Delon, L. C., Nilghaz, A., Cheah, E., Prestidge, C., & Thierry, B. (2020). Unlocking the potential of organ-on-chip models through pumpless and tubeless microfluidics. Advanced Healthcare Materials, 9(11, article no. 1901784), 1-9.
DOI
2020 Pohlen, M., Lavric, Z., Prestidge, C., & Dreu, R. (2020). Preparation, physicochemical characterisation and DoE optimisation of a spray-dried dry emulsion platform for delivery of a poorly soluble drug, simvastatin. AAPS PharmSciTech, 21(4), 1-19.
DOI
2020 Alvebratt, C., Dening, T. J., Åhlén, M., Cheung, O., Strømme, M., Gogoll, A., . . . Bergström, C. A. S. (2020). In vitro performance and chemical stability of lipid-based formulations encapsulated in a mesoporous magnesium carbonate carrier. Pharmaceutics, 12(5, article no. 426), 1-15.
DOI
2020 Delon, L. C., Guo, Z., Kashani, M. N., Yang, C. T., Prestidge, C., & Thierry, B. (2020). Hele Shaw microfluidic device: a new tool for systematic investigation into the effect of the fluid shear stress for organs-on-chips. MethodsX, 7(100980), 1-17.
DOI Scopus7 Europe PMC2
2020 Almasri, R., Joyce, P., Schultz, H. B., Thomas, N., Bremmell, K. E., & Prestidge, C. A. (2020). Porous nanostructure, lipid composition, and degree of drug supersaturation modulate in vitro fenofibrate solubilization in silica-lipid hybrids. Pharmaceutics, 12(7, article no. 687), 1-22.
DOI
2020 Maghrebi, S., Jambhrunkar, M., Joyce, P., & Prestidge, C. A. (2020). Engineering PLGA-lipid hybrid microparticles for enhanced macrophage uptake. ACS Applied Bio Materials, 3(7), 4159-4167.
DOI
2020 Romana, B., Hassan, M. M., Sonvico, F., Garrastazu Pereira, G., Mason, A. F., Thordarson, P., . . . Prestidge, C. A. (2020). A liposome-micelle-hybrid (LMH) oral delivery system for poorly water-soluble drugs: enhancing solubilisation and intestinal transport. European Journal of Pharmaceutics and Biopharmaceutics, 154, 338-347.
DOI
2020 Nimtrakul, P., Williams, D. B., Tiyaboonchai, W., & Prestidge, C. A. (2020). Copolymeric micelles overcome the oral delivery challenges of amphotericin B. Pharmaceuticals, 13(6), 1-14.
DOI
2020 Joyce, P., Dening, T. J., Meola, T. R., Wignall, A., Ulmefors, H., Kovalainen, M., & Prestidge, C. A. (2020). Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats. ACS Applied Bio Materials, 3(11), 7779-7788.
DOI Scopus13 WoS13 Europe PMC10
2020 Joyce, P., Ulmefors, H., Maghrebi, S., Subramaniam, S., Wignall, A., Jõemetsa, S., . . . Prestige, C. A. (2020). Enhancing the cellular uptake and antibacterial activity of rifampicin through encapsulation in mesoporous silica nanoparticles. Nanomaterials, 10(4), 1-16.
DOI WoS31 Europe PMC25
2020 Schultz, H. B., Wignall, A. D., Thomas, N., & Prestidge, C. A. (2020). Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids. International Journal of Pharmaceutics, 582(119264), 1-10.
DOI WoS26
2020 Wright, L., Barnes, T. J., & Prestidge, C. A. (2020). Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction. International Journal of Pharmaceutics, 585(article no. 119488), 119488-1-119488-17.
DOI Scopus36 WoS31 Europe PMC23
2020 Dong, D., Thomas, N., Ramezanpour, M., Alkis, P., Huang, S., Zhao, Y., . . . Vreudge, S. (2020). Inhibition of Staphylococcus aureus and Pseudomonas aeruginosa biofilms by quatsomes in low concentrations. Experimental Biology and Medicine, 245(1), 34-41.
DOI Scopus17 WoS18 Europe PMC12
2019 Pocock, K., Delon, L. C., Khatri, A., Prestidge, C., Gibson, R., Barbe, C., & Thierry, B. (2019). Uptake of silica particulate drug carriers in an intestine-on-a-chip: towards a better in vitro model of nanoparticulate carrier and mucus interactions. Biomaterials Science, 7(6), 2410-2420.
DOI Scopus29 WoS26 Europe PMC21
2019 Klisuric, A., Thierry, B., Delon, L., Prestidge, C. A., & Gibson, R. J. (2019). Highlight Article: Identifying human and murine M cells in vitro. Experimental Biology and Medicine, 244(7), 554-564.
DOI Scopus11 WoS8 Europe PMC10
2019 Subramaniam, S., Thomas, N., Gustafsson, H., Jambhrunkar, M., Kidd, S. P., & Prestidge, C. A. (2019). Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections.. Antibiotics (Basel, Switzerland), 8(2), 15 pages.
DOI Scopus57 WoS45 Europe PMC39
2019 Delon, L. C., Guo, Z., Oszmiana, A., Chien, C. C., Gibson, R., Prestidge, C., & Thierry, B. (2019). A systematic investigation of the effect of the fluid shear stress on Caco-2 cells towards the optimization of epithelial organ-on-chip models. Biomaterials, 225(119521), 1-11.
DOI Scopus142 WoS133 Europe PMC108
2019 Wang, F., Barnes, T. J., & Prestidge, C. A. (2019). Controlling and predicting the dissolution kinetics of thermally oxidised mesoporous silicon particles: towards improved drug delivery. Pharmaceutics, 11(12, article no. 634), 1-15.
DOI
2019 Dening, T. J., Joyce, P., & Prestidge, C. A. (2019). Improving correlations between drug solubilization and in vitro lipolysis by monitoring the phase partitioning of lipolytic species for lipid-based formulations. Journal of pharmaceutical sciences, 108(1), 295-304.
DOI
2019 Bremmell, K. E., & Prestidge, C. A. (2019). Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges. Drug development and industrial pharmacy, 45(3), 349-358.
DOI
2019 Joyce, P., Dening, T. J., Meola, T. R., Schultz, H. B., Holm, R., Thomas, N., & Prestidge, C. A. (2019). Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges. Advanced drug delivery reviews, 142, 102-117.
DOI Scopus106 WoS94 Europe PMC69
2019 Joyce, P., Dening, T. J., Meola, T. R., Gustafsson, H., Kovalainen, M., & Prestidge, C. A. (2019). Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: an in vitro evaluation for the treatment of obesity. European journal of pharmaceutical sciences, 135, 1-11.
DOI Scopus15 WoS14 Europe PMC8
2019 Maghrebi, S., Prestidge, C. A., & Joyce, P. (2019). An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert opinion on drug delivery, 16(5), 507-524.
DOI
2019 Al Bayaty, Y. N., Thomas, N., Jambhrunkar, M., Al Hawwas, M., Kral, A., Thorn, C. R., & Prestidge, C. A. (2019). Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidine. International journal of pharmaceutics, 566, 329-341.
DOI
2019 Partridge, G. J., Rao, S., Woolley, L. D., Pilmer, L., Lymbery, A. J., & Prestidge, C. A. (2019). Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi. Comparative biochemistry and physiology part C: toxicology and pharmacology, 218, 14-20.
DOI Scopus14 Europe PMC8
2019 Dening, T. J., Joyce, P., Kovalainen, M., Gustafsson, H., & Prestidge, C. A. (2019). Spray dried smectite clay particles as a novel treatment against obesity. Pharmaceutical research, 36(1, article no. 21), 1-14.
DOI
2018 Schultz, H. B., Kovalainen, M., Peressin, K. F., Thomas, N., & Prestidge, C. A. (2018). Supersaturated silica-lipid hybrid (super-SLH) oral drug delivery systems: balancing drug loading and in vivo performance. Journal of pharmacology and experimental therapeutics, 370(3), 742-750.
DOI
2018 Thorn, C. R., Prestidge, C. A., Boyd, B. J., & Thomas, N. (2018). Pseudomonas infection responsive liquid crystals for glycoside hydrolase and antibiotic combination. ACS applied bio materials, 1(2), 281-288.
DOI
2018 Schultz, H. B., Thomas, N., Rao, S., & Prestidge, C. A. (2018). Supersaturated silica-lipid hybrids (super-SLH): an improved solid-state lipid-based oral drug delivery system with enhanced drug loading. European journal of pharmaceutics and biopharmaceutics, 125, 13-20.
DOI WoS44 Europe PMC28
2018 Albayaty, Y. N., Thomas, N., Hasan, S., & Prestidge, C. A. (2018). Penetration of topically used antimicrobials through Staphylococcus aureus biofilms: a comparative study using different models. Journal of drug delivery science and technology, 48, 429-436.
DOI
2018 Hasan, S., Albayaty, Y. N. S., Thierry, B., Prestidge, C. A., & Thomas, N. (2018). Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate. European journal of pharmaceutical sciences, 115, 50-56.
DOI
2018 Joyce, P., & Prestidge, C. A. (2018). Synergistic effect of PLGA nanoparticles and submicron triglyceride droplets in enhancing the intestinal solubilisation of a lipophilic weak base. European journal of pharmaceutical sciences, 118, 40-48.
DOI
2018 Meola, T. R., Dening, T. J., & Prestidge, C. A. (2018). Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro. European journal of pharmaceutics and biopharmaceutics, 129, 145-153.
DOI Scopus21 WoS17 Europe PMC10
2018 Joyce, P., Gustafsson, H., & Prestidge, C. A. (2018). Enhancing the lipase-mediated bioaccessibility of omega-3 fatty acids by microencapsulation of fish oil droplets within porous silica particles. Journal of functional foods, 47, 491-502.
DOI
2018 Joyce, P., Gustafsson, H., & Prestidge, C. A. (2018). Engineering intelligent particle-lipid composites that control lipase-mediated digestion. Advances in colloid and interface science, 260, 1-23.
DOI
2018 Dening, T. J., Joyce, P., Webber, J. L., Beattie, D. A., & Prestidge, C. A. (2018). Inorganic surface chemistry and nanostructure controls lipolytic product speciation and partitioning during the digestion of inorganic-lipid hybrid particles. Journal of Colloid and Interface Science, 532, 666-679.
DOI
2018 Dening, T. J., Thomas, N., Rao, S., Van Looveren, C., Cuyckens, F., & Holm, R. (2018). Montmorillonite and laponite clay materials for the solidification of lipid-based formulations for the basic drug blonanserin: in vitro and in vivo investigations. Molecular pharmaceutics, 15(9), 4148-4160.
DOI Scopus24 WoS22 Europe PMC17
2018 Faria, M., Björnmalm, M., Thurecht, K. J., Kent, S. J., Parton, R. G., Kavallaris, M., . . . Caruso, F. (2018). Minimum information reporting in bio-nano experimental literature. Nature nanotechnology, 13(9), 777-785.
DOI Scopus541 Europe PMC363
2018 Ooi, M., Richter, K., Drilling, A., Thomas, N., Prestidge, C. A., James, C., . . . Wormald, P. J. (2018). Safety and efficacy of topical chitogel- deferiprone- gallium protoporphyrin in a sheep sinusitis model. Frontiers in Microbiology, 9(917), 1-9.
DOI Scopus17 WoS16 Europe PMC12
2018 Su, Y. W., Chim, S. M., Zhou, L., Hassanshahi, M., Chung, R., Fan, C., . . . Xian, C. J. (2018). Osteoblast derived-neurotrophin‑3 induces cartilage removal proteases and osteoclast-mediated function at injured growth plate in rats. Bone, 116, 232-247.
DOI Scopus18 WoS16 Europe PMC13
2018 Wright, L., Rao, S., Thomas, N., Boulos, R. A., & Prestidge, C. A. (2018). Ramizol<sup>®</sup> encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: <i>in vitro</i> and <i>in vivo</i> evaluation. Drug Development and Industrial Pharmacy, 44(9), 1451-1457.
DOI Scopus17 WoS14 Europe PMC9
2017 Richter, K., Thomas, N., Claeys, J., McGuane, J., Prestidge, C., Coenye, T., . . . Vreugde, S. (2017). A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity. Antimicrobial Agents and Chemotherapy, 61(6), e00481-17-1-e00481-17-11.
DOI Scopus71 WoS68 Europe PMC51
2017 Richter, K., Facal, P., Thomas, N., Vandecandelaere, I., Ramezanpour, M., Cooksley, C., . . . Vreugde, S. (2017). Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections. ACS Applied Materials and Interfaces, 9(26), 21631-21638.
DOI Scopus49 WoS45 Europe PMC32
2017 Richter, K., Thomas, N., Zhang, G., Prestidge, C., Coenye, T., Wormald, P. -J., & Vreugde, S. (2017). Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants. Frontiers in Cellular and Infection Microbiology, 7(JUN), 280-1-280-10.
DOI Scopus57 WoS48 Europe PMC37
2017 Chang, P. K. C., Prestidge, C. A., & Bremmell, K. E. (2017). Interfacial analysis of siRNA complexes with poly-ethylenimine (PEI) or PAMAM dendrimers in gene delivery. Colloids and surfaces B: biointerfaces, 158, 370-378.
DOI
2017 Hasan, S., Thomas, N., Thierry, B., & Prestidge, C. A. (2017). Controlled and localized nitric oxide precursor delivery from chitosan gels to staphylococcus aureus biofilms. Journal of pharmaceutical sciences, 106(12), 3556-3563.
DOI
2017 Joyce, P., Yasmin, R., Bhatt, A., Boyd, B. J., Pham, A., & Prestidge, C. A. (2017). Comparison across three hybrid lipid-based drug delivery systems for improving the oral absorption of the poorly water-soluble weak base cinnarizine. Molecular pharmaceutics, 14(11), 4008-4018.
DOI
2017 Mukherjee, S., Prestidge, C. A., Orgeig, S., Panda, A. K., & Moulik, S. P. (2017). Physicochemical Investigation on the Pulmonary Surfactant of Some Vertebrates. Journal of surface science and technology, 33(3-4), 127-136.
DOI
2017 Joyce, P., Dening, T. J., Gustafsson, H., & Prestidge, C. A. (2017). Modulating the lipase-mediated bioactivity of particle-lipid conjugates through changes in nanostructure and surface chemistry. European journal of lipid science and technology, 119(12, article no. 1700213), 1-9.
DOI
2017 Pocock, K., Delon, L., Bala, V., Rao, S., Priest, C., Prestidge, C., & Thierry, B. (2017). Intestine-on-a-chip microfluidic model for efficient in vitro screening of oral chemotherapeutic uptake. ACS biomaterials science and engineering, 3(6), 951-959.
DOI Scopus91 WoS85 Europe PMC68
2017 Cifuentes Rius, A., Ivask, A., Sporleder, E., Kaur, I., Assan, Y., Rao, S., . . . Voelcker, N. H. (2017). Dual-action cancer therapy with targeted porous silicon nanovectors. Small, 13(1701201), 1-6.
DOI Scopus32 WoS32 Europe PMC16
2017 Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2017). Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies. International Journal of Pharmaceutics, 526(1-2), 95-105.
DOI Scopus29 WoS27 Europe PMC15
2017 Yasmin, R., Rao, S., Bremmell, K. E., & Prestidge, C. (2017). Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs. European journal of pharmaceutical sciences, 96, 508-514.
DOI Scopus21 WoS19 Europe PMC10
2017 Hasan, S., Thomas, N., Thierry, B., & Prestidge, C. A. (2017). Biodegradable nitric oxide precursor-loaded micro- and nanoparticles for the treatment of Staphylococcus aureus biofilms. Journal of materials chemistry B, 5(5), 1005-1014.
DOI
2016 Chang, P. K., Prestidge, C. A., Barnes, T. J., & Bremmell, K. E. (2016). Impact of PEGylation and non-ionic surfactants on the physical stability of the therapeutic protein filgrastim (G-CSF). RSC advances, 6(82), 78970-78978.
DOI
2016 Joyce, P., Barnes, T. J., Boyd, B. J., & Prestidge, C. A. (2016). Porous nanostructure controls kinetics, disposition and self-assembly structure of lipid digestion products. RSC advances, 6(82), 78385-78395.
DOI
2016 Bala, V., Rao, S., & Prestidge, C. A. (2016). Facilitating gastrointestinal solubilisation and enhanced oral absorption of SN38 using a molecularly complexed silica-lipid hybrid delivery system. European journal of pharmaceutics and biopharmaceutics, 105, 32-39.
DOI Scopus21 Europe PMC15
2016 Rao, S., Prestidge, C. A., Miesel, L., Sweeney, D. F., Shinabarger, D. L., & Boulos, R. A. (2016). Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis. The journal of antibiotics, 69(12), 879-884.
DOI Scopus21 Europe PMC16
2016 Yasmin, R., Rao, S., Bremmell, K. E., & Prestidge, C. A. (2016). Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs. AAPS Journal, 18(4), 876-885.
DOI Scopus8 WoS8 Europe PMC5
2016 Rao, S., & Prestidge, C. A. (2016). Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery. Expert Opinion on Drug Delivery, online(5), 1-17.
DOI Scopus107 WoS90 Europe PMC52
2016 Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2016). Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro. European journal of pharmaceutics and biopharmaceutics, 101, 33-42.
DOI Scopus31 Europe PMC17
2016 Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2016). Oral nanomedicine approaches for the treatment of psychiatric illnesses. Journal of controlled release, 223, 137-156.
DOI Scopus51 WoS39 Europe PMC26
2016 Bala, V., Rao, S., Li, P., Wang, S., & Prestidge, C. A. (2016). Lipophilic prodrugs of SN38: synthesis and in vitro characterization toward oral chemotherapy. Molecular Pharmaceutics, 13(1), 287-294.
DOI Scopus66 WoS58 Europe PMC44
2016 Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2016). Novel nanostructured solid materials for modulating oral drug delivery from solid-state lipid-based drug delivery systems. AAPS journal, 18(1), 23-40.
DOI Scopus64 WoS56 Europe PMC31
2016 Dening, T. J., Joyce, P., Rao, S., Thomas, N., & Prestidge, C. A. (2016). Nanostructured montmorillonite clay for controlling the lipase-mediated digestion of medium chain triglycerides. ACS applied materials and interfaces, 8(48), 32732-32742.
DOI Scopus40 Europe PMC18
2016 Joyce, P., Whitby, C. P., & Prestidge, C. A. (2016). Nanostructuring biomaterials with specific activities towards digestive enzymes for controlled gastrointestinal absorption of lipophilic bioactive molecules. Advances in colloid and interface science, 237, 52-75.
DOI
2016 Pocock, K. J., Gao, X., Wang, C., Priest, C., Prestidge, C. A., Mawatari, K., . . . Thierry, B. (2016). Low-temperature bonding process for the fabrication of hybrid glass-membrane organ-on-a-chip devices. Journal of micro/nanolithography, MEMS, and MOEMS, 15(4), 1-9.
DOI Scopus12
2016 Joyce, P., Whitby, C. P., & Prestidge, C. A. (2016). Interfacial processes that modulate the kinetics of lipase-mediated catalysis using porous silica host particles. RSC advances, 6(49), 43802-43813.
DOI
2016 Liau, J. J., Prestidge, C. A., Hook, S., & Barnes, T. J. (2016). Development of a multi-compartmental oral vaccine delivery system. Drug delivery letters, 6(1), 57-62.
DOI
2016 Bala, V., Rao, S., Bateman, E., Keefe, D., Wang, S., & Prestidge, C. (2016). Enabling oral SN38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery system. Molecular Pharmaceutics, 13(10), 3518-3525.
DOI Scopus45 WoS43 Europe PMC29
2016 Thomas, N., Thorn, C., Richter, K., Thierry, B., & Prestidge, C. (2016). Efficacy of poly-lactic-co-glycolic acid micro- and nanoparticles of ciprofloxacin against bacterial biofilms. Journal of Pharmaceutical Sciences, 105(10), 3115-3122.
DOI Scopus48 WoS46 Europe PMC33
2016 Richter, K., Ramezanpour, M., Thomas, N., Prestidge, C. A., Wormald, P. J., & Vreugde, S. (2016). Mind “De GaPP”: in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms. International Forum of Allergy and Rhinology, 6(7), 737-743.
DOI Scopus45 WoS41 Europe PMC37
2016 Hasan, S., Thomas, N., Thierry, B., Vreugde, S., Wormald, P., & Prestidge, C. (2016). Recent trends on the use of nanoparticles for nitric oxide delivery in antimicrobial applications. Drug Delivery Letters, 6(1), 3-10.
DOI Scopus2
2016 Joyce, P., Kempson, I., & Prestidge, C. A. (2016). Orientating lipase molecules through surface chemical control for enhanced activity: A QCM-D and ToF-SIMS investigation. Colloids and Surfaces B Biointerfaces, 142, 173-181.
DOI Scopus32 WoS30 Europe PMC16
2015 Joyce, P., Kempson, I., & Prestidge, C. A. (2015). QCM-D and ToF-SIMS Investigation to Deconvolute the Relationship between Lipid Adsorption and Orientation on Lipase Activity. Langmuir, 31(37), 10198-10207.
DOI Scopus25 WoS25 Europe PMC14
2015 Delalat, B., Sheppard, V. C., Rasi, G. S., Rao, S., Prestidge, C. A., McPhee, G., . . . Voelcker, N. H. (2015). Targeted drug delivery using genetically engineered diatom biosilica. Nature Communications, 6(8791), 1-11.
DOI Scopus258 WoS225 Europe PMC133
2015 Jardeleza, C., Thierry, B., Rao, S., Rajiv, S., Drilling, A., Miljkovic, D., . . . Wormald, P. (2015). An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis. Translational Research, 166(6), 683-692.
DOI Scopus33 WoS31 Europe PMC26
2015 Dong, D., Thomas, N., Thierry, B., Vreugde, S., Prestidge, C., & Wormald, P. (2015). Distribution and Inhibition of liposomes on Staphylococcus aureus and Pseudomonas aeruginosa biofilm. PLoS One, 10(6), e0131806.
DOI Scopus81 WoS76 Europe PMC47
2015 Thomas, N., Dong, D., Richter, K., Ramezanpour, M., Vreugde, S., Thierry, B., . . . Prestidge, C. (2015). Quatsomes for the treatment of Staphylococcus aureus biofilm. Journal of Materials Chemistry B, 3(14), 2770-2777.
DOI Scopus30 WoS28 Europe PMC17
2015 Rao, S., Richter, K., Nguyen, T., Boyd, B., Porter, C., Tan, A., & Prestidge, C. (2015). Pluronic-functionalized silica-lipid hybrid microparticles: improving the oral delivery of poorly water-soluble weak bases. Molecular Pharmaceutics, 12(12), 4424-4433.
DOI Scopus32 WoS30 Europe PMC21
2015 Miller, D., Parsons, A., Bresland, J., Herde, P., Pham, D., Tan, A., . . . Butler, R. (2015). A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine. Journal of Zhejiang University. Science B, 16(7), 586-592.
DOI Scopus15 WoS13 Europe PMC11
2015 Bhatt, A. B., Barnes, T. J., & Prestidge, C. A. (2015). Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. Current drug delivery, 12(1), 47-55.
DOI
2015 Barnes, T. J., & Prestidge, C. A. (2015). Recent advances in porous silicon-based therapeutic delivery. Therapeutic Delivery, 6(2), 97-100.
DOI
2015 Liau, J. J., Hook, S., Prestidge, C. A., & Barnes, T. J. (2015). A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery. European Journal of Pharmaceutics and Biopharmaceutics, 97, 15-21.
DOI
2015 Alinaghi, A., Tan, A., Rao, S., & Prestidge, C. A. (2015). Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems. Current Drug Delivery, 12(1), 16-25.
DOI Scopus12 WoS12 Europe PMC7
2015 Joyce, P., Whitby, C. P., & Prestidge, C. A. (2015). Bioactive hybrid particles from poly(D,L -lactide-co-glycolide) nanoparticle stabilized lipid droplets. ACS applied materials and interfaces, 7(31), 17460-17470.
DOI
2014 Rao, S., Tan, A., Boyd, B. J., & Prestidge, C. A. (2014). Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin. Nanomedicine, 9(18), 2745-2759.
DOI Scopus34 WoS27 Europe PMC19
2014 Rao, S., Tan, A., Thomas, N., & Prestidge, C. A. (2014). Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases. Journal of controlled release, 193, 174-187.
DOI Scopus35 WoS28 Europe PMC17
2014 Romana, B., Batger, M., Prestidge, C. A., Colombo, G., & Sonvico, F. (2014). Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems. Current topics in medicinal chemistry, 14(9), 1182-1193.
DOI
2014 Joyce, P., Tan, A., Whitby, C. P., & Prestidge, C. A. (2014). The role of porous nanostructure in controlling lipase-mediated digestion of lipid loaded into silica particles. Langmuir, 30(10), 2779-2788.
DOI
2014 Phan, S., Salentinig, S., Prestidge, C. A., & Boyd, B. J. (2014). Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems. Drug delivery and translational research, 4(3), 275-294.
DOI
2014 Jardeleza, C., Rao, S., Thierry, B., Gajjar, P., Vreugde, S., Prestidge, C., & Wormald, P. (2014). Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms. PLoS One, 9(3), 1-9.
DOI Scopus44 WoS39 Europe PMC25
2014 Yasmin, R., Tan, A., Bremmell, K. E., & Prestidge, C. A. (2014). Lyophilized silica-lipid hybrid carriers for poorly water-soluble drugs : physicochemical and in vitro pharmaceutical investigations. Journal of pharmaceutical sciences, 103(9), 2950-2959.
DOI Europe PMC15
2014 Fong, W. K., Salentinig, S., Prestidge, C. A., Mezzenga, R., Hawley, A., & Boyd, B. (2014). Generation of geometrically ordered lipid-based liquid-crystalline nanoparticles using biologically relevant enzymatic processing. Langmuir, 30(19), 5373-5377.
DOI
2014 Roy, B., Panda, A. K., Parimi, S., Ametov, I., Barnes, T., & Prestidge, C. A. (2014). Physio-chemical studies on the interaction of dendrimers with lipid bilayers. 1. effect of dendrimer generation and liposome surface charge.. Journal of oleo science, 63(11), 1185-1193.
DOI
2014 Li, P., Tan, A., Prestidge, C. A., Nielsen, H. M., & Mullertz, A. (2014). Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading. International journal of pharmaceutics, 477(1-2), 390-398.
DOI Scopus91 WoS83 Europe PMC56
2014 Tan, A., Colliat Dangus, P., Whitby, C. P., & Prestidge, C. A. (2014). Controlling the enzymatic digestion of lipids using hybrid nanostructured materials. ACS applied materials and interfaces, 6(17), 5363-5371.
DOI
2013 Yadollahi, R., Vasilev, K., Prestidge, C., & Simovic, S. (2013). Polymeric nanosuspensions for enhanced dissolution of water insoluble drugs. Journal of nanomaterials, 2013(article no. 170201), 1-10.
DOI
2013 Barnes, T. J., Jarvis, K. L., & Prestidge, C. A. (2013). Recent advances in porous silicon technology for drug delivery. Therapeutic delivery, 4(7), 811-823.
DOI
2013 Tan, A., Eskandar, N. G., Rao, S., & Prestidge, C. A. (2013). First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen. Drug delivery and translational research, 4(3), 212-221.
DOI Scopus72 WoS72 Europe PMC46
2013 Bala, V., Rao, S., Boyd, B. J., & Prestidge, C. A. (2013). Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. Journal of controlled release, 172(1), 48-61.
DOI Scopus184 Europe PMC125
2013 Tan, A., Rao, S., & Prestidge, C. A. (2013). Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharmaceutical research, 30(12), 2993-3017.
DOI Scopus154 WoS139 Europe PMC94
2013 Wang, F., Barnes, T. J., & Prestidge, C. A. (2013). Celecoxib confinement within mesoporous silicon for enhanced oral bioavailability. Mesoporous Biomaterials, 1(1), 1-16.
DOI
2013 Kempson, I. M., Chang, P., Bremmell, K., & Prestidge, C. A. (2013). Low temperature thermal dependent filgrastim adsorption behavior detected with ToF-SIMS. Langmuir, 29(50), 15573-15578.
DOI Scopus9 WoS10 Europe PMC6
2013 Bremmell, K. E., Tan, A., Martin, A., & Prestidge, C. A. (2013). Tableting lipid-based formulations for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid microparticles. Journal of pharmaceutical sciences, 102(2), 684-693.
DOI Europe PMC18
2013 Lim, S., Kumar, R., Akkamsetty, Y., Wang, W., Ho, K., Neilsen, P., . . . Callen, D. (2013). Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine. BMC Cancer, 13(113), 1-11.
DOI Scopus9 WoS6 Europe PMC4
2013 Tan, A., & Prestidge, C. (2013). Improving the performance of lipid formulations: nanoparticle layers and solid hybrid particles. American pharmaceutical review, 16(7), 1-8.
2013 Phan, S., Hawley, A., Mulet, X., Waddington, L., Prestidge, C. A., & Boyd, B. J. (2013). Structural aspects of digestion of medium chain triglycerides studied in real time using sSAXS and cryo-TEM. Pharmaceutical research, 30(12), 3088-3100.
DOI
2013 Nguyen, T. H., Tan, A., Santos, L., Ngo, D., Edwards, G. A., Porter, C. J. H., . . . Boyd, B. J. (2013). Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: an in vivo evaluation. Journal of controlled release, 167(1), 85-91.
DOI Scopus48 WoS46 Europe PMC31
2012 Whitby, C. P., Lim, L. H., Ghouchi, E. N., Simovic, S., & Prestidge, C. A. (2012). Poly(lactic-co-glycolic acid) as a particulate emulsifier. Journal of colloid and interface science, 375(1), 142-147.
DOI WoS24 Europe PMC17
2012 Tan, A., Martin, A. L., Nguyen, T. H., Boyd, B., & Prestidge, C. A. (2012). Hybrid nanomaterials that mimic the food effect : controlling enzymatic digestion for enhanced oral drug absorption. Angewandte chemie (international edition), 51(22), 5475-5479.
DOI Scopus48 WoS43 Europe PMC30
2012 Chan, J. G. Y., Chan, H. K., Prestidge, C. A., Denman, J. A., Young, P. M., & Traini, D. (2012). A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics. European journal of pharmaceutics and biopharmaceutics, 83(2), 285-292.
DOI Scopus84 WoS77 Europe PMC57
2012 Simovic, S., Barnes, T. J., Tan, A., & Prestidge, C. A. (2012). Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids. Nanoscale, 4(4), 1220-1230.
DOI
2012 Dong, Y. D., Larson, I., Barnes, T. J., Prestidge, C. A., Allen, S., Chen, X., . . . Boyd, B. J. (2012). Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications. Langmuir, 28(37), 13485-13495.
DOI Scopus36 Europe PMC16
2012 Tan, A., & Prestidge, C. (2012). Nanostructured silica-lipid hybrid microparticles: A supersaturating carrier for water- and lipid-resistant compounds. Chemistry Letters, 41(10), 1334-1336.
DOI
2012 Jarvis, K. L., Barnes, T. J., & Prestidge, C. A. (2012). Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications. Advances in colloid and interface science, 175, 25-38.
DOI
2012 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2012). Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol. International journal of pharmaceutics, 423(2), 384-391.
DOI
2011 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2011). Interactions of hydrophilic silica nanoparticles and classical surfactants at non-polar oil-water interface. Journal of colloid and interface science, 358(1), 217-225.
DOI
2011 Jarvis, K. L., Barnes, T. J., & Prestidge, C. A. (2011). Surface chemical modification to control molecular interactions with porous silicon. Journal of colloid and interface science, 363(1), 327-333.
DOI
2011 Simovic, S., Ghouchi Eskandar, N., & Prestidge, C. A. (2011). Pickering emulsions for dermal delivery. Journal of drug delivery science and technology, 21(1), 123-133.
DOI
2011 Barnes, T. J., Kempson, I. M., & Prestidge, C. A. (2011). Surface analysis for compositional, chemical and structural imaging in pharmaceutics with mass spectrometry: A ToF-SIMS perspective. International Journal of Pharmaceutics, 417(1-2), 61-69.
DOI Scopus49 WoS49 Europe PMC19
2011 Dong, Y. D., Larson, I., Barnes, T. J., Prestidge, C. A., & Boyd, B. J. (2011). Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. ACS applied materials and interfaces, 3(5), 1771-1780.
DOI
2011 Tan, A., Davey, A. K., & Prestidge, C. A. (2011). Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of Celecoxib. Pharmaceutical research, 28(9), 2273-2287.
DOI
2011 Lim, L. H., Tan, A., Simovic, S., & Prestidge, C. A. (2011). Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance. International journal of pharmaceutics, 409(1-2), 297-306.
DOI WoS30 Europe PMC16
2011 Simovic, S., Ghouchi-Eskandar, N., Sinn, A., Losic, D., & Prestidge, C. (2011). Silica materials in drug delivery applications. Current Drug Discovery Technologies, 8(3), 250-268.
DOI Scopus65 Europe PMC32
2011 Kurkuri, M., Al-ejeh, F., Shi, J., Palms, D., Prestidge, C., Griesser, H., . . . Thierry, B. (2011). Plasma functionalized PDMS microfluidic chips: towards point-of-care capture of circulating tumor cells. Journal of Materials Chemistry, 21(24), 8841-8848.
DOI Scopus36 WoS34
2010 Parimi, S., Barnes, T., Callen, D., & Prestidge, C. (2010). Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers. Biomacromolecules, 11(2), 382-389.
DOI Scopus47 WoS46 Europe PMC27
2010 Tan, A., Simovic, S., Davey, A., Rades, T., Boyd, B., & Prestidge, C. (2010). Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Molecular Pharmaceutics, 7(2), 522-532.
DOI Scopus85 WoS78 Europe PMC53
2010 Simovic, S., Hui, H., Song, Y., Davey, A., Rades, T., & Prestidge, C. (2010). An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. Journal of Controlled Release, 143(3), 367-373.
DOI Scopus87 WoS65 Europe PMC38
2010 Kempson, I. M., Martin, A. L., Denman, J. A., French, P. W., Prestidge, C. A., & Barnes, T. J. (2010). Detecting the presence of denatured human serum albumin in an adsorbed protein monolayer using TOF-SIMS. Langmuir, 26(14), 12075-12080.
DOI Scopus33 WoS33 Europe PMC23
2010 Kempson, I. M., Barnes, T. J., & Prestidge, C. A. (2010). Use of TOF-SIMS to Study Adsorption and Loading Behavior of Methylene Blue and Papain in a Nano-Porous Silicon Layer. Journal of the American Society for Mass Spectrometry, 21(2), 254-260.
DOI Scopus28 WoS23 Europe PMC10
2010 Vellore Janarthanan, M., Barnes, T. J., & Prestidge, C. A. (2010). Silica nanoparticle coated liposomes : a new type of hybrid nanocapsule for proteins. International journal of pharmaceutics, 392(1/2), 285-293.
DOI
2010 Wang, F. F., He, H., Barnes, T. J., Barnett, C., & Prestidge, C. A. (2010). Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Molecular pharmaceutics, 7(1), 227-236.
DOI
2010 Jarvis, K., Barnes, T. J., & Prestidge, C. A. (2010). Thermal oxidation for controlling protein interactions with porous silicon. Langmuir, 26(17), 14316-14322.
DOI
2010 Simovic, S., Heard, P., & Prestidge, C. A. (2010). Hybrid lipid-silica microcapsules engineered by phase coacervation of Pickering emulsions to enhance lipid hydrolysis. Physical chemistry chemical physics, 12(26), 7162-7170.
DOI
2010 Panda, A., Vasilev, K. A., Orgeig, S., & Prestidge, C. A. (2010). Thermodynamic and structural studies of mixed monolayers : mutual mixing of DPPC and DPPG with DoTAP at the air-water interface. Materials Science & Engineering C : Biomimetic & Supramolecular Systems, 30(4), 542-548.
DOI
2009 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2009). Mechanistic insight into the dermal delivery from nanoparticle-coated submicron O/W emulsions. Journal of Pharmaceutical Sciences, 99(2), 890-904.
DOI
2009 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2009). Nanoparticle coated emulsions as novel dermal delivery vehicles. Current drug delivery, 6(4), 367-373.
DOI
2009 Er, Y., Barnes, T. J., Fornasiero, D., & Prestidge, C. A. (2009). The encapsulation and release of guanosine from PEGylated liposomes. Journal of liposome research, 19(1), 29-36.
DOI
2009 Eskandar, N. G., Simovic, S., & Prestidge, C. A. (2009). Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all trans-retinol. Pharmaceutical research, 26(7), 1764-1775.
DOI
2009 Eskandar, N. G., Simovic, S., & Prestidge, C. A. (2009). Chemical stability and phase distribution of all-trans-retinol in nanoparticle-coated emulsions. International journal of pharmaceutics, 376(1/2), 186-194.
DOI
2009 Simovic, S., Heard, P., Hui, H., Song, Y., Peddie, F., Davey, A., . . . Prestidge, C. (2009). Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Molecular Pharmaceutics, 6(3), 861-872.
DOI Scopus104 WoS93 Europe PMC57
2009 Tan, A., Simovic, S., Davey, A., Rades, T., & Prestidge, C. (2009). Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. Journal of Controlled Release, 134(1), 62-70.
DOI Scopus165 WoS151 Europe PMC98
2008 Jarvis, K., Barnes, T., Badalyan, A., Pendleton, P., & Prestidge, C. (2008). Impact of thermal oxidation on the adsorptive properties and structure of porous silicon particles. The Journal of Physical Chemistry Part C: Nanomaterials and Interfaces, 112(26), 9717-9722.
DOI Scopus34 WoS29
2008 Simovic, S., & Prestidge, C. A. (2008). Colloidosomes from the Controlled Interaction of Submicrometer Triglyceride Droplets and Hydrophilic Silica Nanoparticles. Langmuir, 24(14), 7132-7137.
DOI
2008 Parimi, S., Barnes, T. J., & Prestidge, C. A. (2008). PAMAM dendrimer interactions with supported lipid bilayers : a kinetic and mechanistic investigation. Langmuir, 24(23), 13532-13539.
DOI
2008 Britcher, L. G., Barnes, T. J., Griesser, H. J., & Prestidge, C. A. (2008). PEGylation of Porous Silicon Using Click Chemistry. Langmuir, 24(15), 7625-7627.
DOI
2008 Saiki, Y., Horn, R. G., & Prestidge, C. A. (2008). Droplet structure instability in concentrated emulsions. Journal of colloid and interface science, 320(2), 569-574.
DOI
2008 Barnes, T. J., Jarvis, K., & Prestidge, C. A. (2008). Aqueous and Thermal Oxidation of Porous Silicon Microparticles: Implications on Molecular Interactions. Langmuir, 24(24), 14222-14226.
DOI
2008 Barnes, T. J., Ametov, I., & Prestidge, C. A. (2008). Dendrimer adsorption on charged particulate surfaces. Asia-Pacific Journal of Chemical Engineering, 3(1), 13-17.
DOI
2008 Barnes, T. J., Ametov, I., & Prestidge, C. A. (2008). Naphthalene sulphonate functionalized dendrimers at the solid-liquid interface: influence of core type, ionic strength and competitive ionic adsorbates. Langmuir, 24(21), 12398-12404.
DOI
2008 Prestidge, C. A., Barnes, T. J., MierczynsKa-Vasilev, A., Kempson, I., Peddie, F., & Barnett, C. (2008). Peptide and protein loading into porous silicon wafers. Physica Status Solidi A Applications and Materials Science, 205(2), 311-315.
DOI Scopus42 WoS39
2008 Saiki, Y., Horn, R. G., & Prestidge, C. A. (2008). Rheological transition of concentrated emulsions during successive shearing cycles. Journal of colloid and interface science, 327(2), 440-445.
DOI
2007 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2007). Synergistic effect of silica nanoparticles and charged surfactants in the formation and stability of submicron oil-in-water emulsions. Physical chemistry chemical physics, 9(48), 6426.
DOI
2007 Simovic, S., & Prestidge, C. A. (2007). Nanoparticle layers controlling drug release from emulsions. European journal of pharmaceutics and biopharmaceutics, 67(1), 39-47.
DOI
2007 Prestidge, C. A., Barnes, T. J., & Skinner, W. M. (2007). Time-of-flight secondary-ion mass spectrometry for the surface characterization of solid-state pharmaceuticals. Journal of pharmacy and pharmacology, 59(2), 251-259.
DOI Scopus22 WoS18 Europe PMC8
2007 Prestidge, C. A., Barnes, T. J., Mierczynska Vasilev, A., Skinner, W. M., Peddie, F., & Barnett, C. (2007). Loading and release of a model protein from porous silicon powders. Physica status solidi. A : applications and materials science, 204(10), 3361-3366.
DOI Scopus42 WoS35
2007 Saiki, Y., Prestidge, C. A., & Horn, R. G. (2007). Effects of droplet deformability on emulsion rheology. Colloids and surfaces A : physicochemical and engineering aspects, 299(1-3), 65-72.
DOI
2007 Prestidge, C. A., Barnes, T. J., Lau, C. H., Barnett, C., Loni, A., & Canham, L. (2007). Mesoporous silicon: a platform for the delivery of therapeutics. Expert Opinion on Drug Delivery, 4(2), 101-110.
DOI
2006 Markovic, N., Agatonovic Kustrin, S., Glass, B., & Prestidge, C. A. (2006). Physical and thermal characterisation of chiral omeprazole sodium salts. Journal of pharmaceutical and biomedical analysis, 42(1), 25-31.
DOI
2006 Bremmell, K. E., Evans, A. M., & Prestidge, C. A. (2006). Deformation and nano-rheology of red blood cells. Colloids and surfaces B : biointerfaces, 50(1), 43-48.
DOI Scopus78 WoS69 Europe PMC42
2005 Gillies, G. S., & Prestidge, C. A. (2005). Colloid probe AFM investigation of the influence of cross-linking on the interaction behavior and nano-rheology of colloidal droplets. Langmuir, 21(26), 12342-12347.
DOI
2005 Simovic, S., & Prestidge, C. A. (2005). Nanoparticles at the polydimethylsiloxane droplet/water interface. Australian journal of chemistry, 58(9), 664-666.
DOI
2005 Muster, T. H., & Prestidge, C. A. (2005). Water adsorption kinetics and contact angles of pharmaceutical powders. Journal of Pharmaceutical Sciences.
2005 Saiki, Y., & Prestidge, C. A. (2005). Droplet deformability and emulsion rheology: steady and dynamic behaviour. Korea-Australia Rheology Journal.
2004 Prestidge, C. A., & Gillies, G. S. (2004). Interaction forces, deformation and nano-rheology of emulsion droplets as determined by colloid probe AFM. Advances in colloid and interface science, 108-109, 197-205.
DOI
2004 Ametov, I., & Prestidge, C. A. (2004). Hydrophobic interactions in concentrated colloidal suspensions. The journal of physical chemistry part B : materials, surfaces, interfaces and biophysical, 108(32), 12116-12122.
DOI
2004 Prestidge, C. A., Barnes, T. J., & Simovic, S. (2004). Polymer and particle adsorption at the PDMS droplet-water interface. Advances in colloid and interface science, 108-109, 105-118.
DOI
2004 Simovic, S., & Prestidge, C. A. (2004). Nanoparticles of varying hydrophobicity at the emulsion droplet-water interface. Langmuir, 20(19), 8357-8365.
DOI
2004 Er, Y., Prestidge, C. A., & Fornasiero, D. (2004). Attenuated total reflectance infrared studies of liposome adsorption at the solid-liquid interface. Colloids and surfaces B : biointerfaces, 36(3-4), 147-153.
DOI
2003 Simovic, S., & Prestidge, C. A. (2003). Adsorption of hydrophobic silica nanoparticles at the PDMS droplet-water interface. Langmuir, 19(20), 8364-8370.
DOI
2003 Simovic, S., & Prestidge, C. A. (2003). Hydrophilic silica nanoparticles at the PDMS droplet-water interface. Langmuir, 19(9), 3785-3792.
DOI
2002 Koh, A., Prestidge, C. A., Ametov, I., & Saunders, B. (2002). Temperature-induced gelation of emulsions stabilised by responsive copolymers. Physical chemistry chemical physics, 4(1), 96-102.
DOI
2002 Muster, T. H., & Prestidge, C. A. (2002). Face specific surface properties of pharmaceutical crystals. Journal of pharmaceutical sciences, 91(6), 1432-1444.
DOI
2002 Gillies, G. S., Prestidge, C. A., & Attard, P. J. (2002). An AFM study of the deformation and nanorheology of cross-linked PDMS droplets. Langmuir, 18(5), 1674-1679.
DOI
2002 Muster, T. H., & Prestidge, C. A. (2002). Application of time-dependent sessile drop contact angles on compacts to characterise the surface energetics of sulfathiazole crystals. International journal of pharmaceutics, 234(1-2), 43-54.
DOI
2002 Addai Mensah, J., Li, J., & Prestidge, C. A. (2002). The structure and interactions of species in supersaturated caustic aluminate solutions. Developments in Chemical Engineering and Mineral Processing: Australasian Research Journal, 10(5-6), 553-566.
DOI Scopus3
2002 Addai Mensah, J., Li, J., & Prestidge, C. A. (2002). Aggregation behaviour of gibbsite crystals in supersaturated sodium and potassium aluminate liquors. Developments in Chemical Engineering and Mineral Processing: Australasian Research Journal, 10(5-6), 539-551.
DOI Scopus10
2001 Morey, M. S., Grano, S. R., Ralston, J., Prestidge, C. A., & Verity, B. (2001). The electrochemistry of PbII activated sphalerite in relation to flotation. Minerals engineering, 14(9), 1009-1017.
DOI Scopus19 WoS19
2001 Muster, T. H., Prestidge, C. A., & Hayes, R. (2001). Water adsorption kinetics and contact angles of silica particles. Colloids and surfaces A : physicochemical and engineering aspects, 176(2-3), 253-266.
DOI
2001 Gillies, G. S., Prestidge, C. A., & Attard, P. J. (2001). Determination of the separation in colloid probe atomic force microscopy of deformable bodies. Langmuir, 17(25), 7955-7956.
DOI
2001 Bandini, P., Prestidge, C. A., & Ralston, J. (2001). Colloidal iron oxide slime coatings and galena particle flotation. Minerals Engineering, 14(5), 487-497.
DOI
2000 Prestidge, C. A., & Kapsabelis, S. (2000). Adsorption of Ethyl(hydroxyethyl)cellulose onto silica particles. Journal of colloid and interface science, 228(2), 297-305.
DOI
2000 Prestidge, C. A., & Ametov, I. (2000). Cation effects during aggregation and agglomeration of gibbsite particles under synthetic Bayer crystallisation conditions. Journal of crystal growth, 209(4), 924-933.
DOI
2000 Prestidge, C. A., & Addai Mensah, J. (2000). Secondary nucleation of gibbsite crystals from synthetic Bayer liquors. Journal of crystal growth.
DOI
2000 Prestidge, C. A., & Addai Mensah, J. (2000). Viscosity, density, and refractive index of aqueous sodium and pottasium aluminate solutions. Journal of Chemical and Engineering Data.
DOI
2000 Prestidge, C. A., & Barnes, T. J. (2000). PEO-PPO-PEO block copolymers at the emulsion droplet-water interface. Langmuir, 16(9), 4116-4121.
DOI
2000 Tsatouhas, G., & Prestidge, C. A. (2000). Wettability studies of morphine sulfate powders. International journal of pharmaceutics, 198(2), 201-212.
DOI
2000 Prestidge, C. A., & Addai Mensah, J. (2000). The influence of alkali metal ions on homogeneous nucleation of AI(OH)(3) crystals from supersaturated caustic aluminate solutions. Journal of colloid and interface science.
DOI
2000 Li, J., Prestidge, C. A., & Addai Mensah, J. (2000). Viscosity, density, and refractive index of aqueous sodium and potassium aluminate solutions. Journal of Chemical and Engineering Data, 45(4), 665-671.
DOI Scopus29 WoS25
2000 Li, J., Prestidge, C. A., & Addai Mensah, J. (2000). Secondary nucleation of gibbsite crystals from synthetic Bayer liquors: effect of alkali metal Ions. Journal of Crystal Growth, 219(4), 451-464.
DOI Scopus34 WoS30
2000 Li, J., Prestidge, C. A., & Addai Mensah, J. (2000). The influence of alkali metal ions on homogeneous nucleation of Al(OH)(3) crystals from supersaturated caustic aluminate solutions. Journal of colloid and interface science, 224(2), 317-324.
DOI Scopus46 WoS40 Europe PMC8
1999 Prestidge, C. A., Ametov, I., & Addai Mensah, J. (1999). Rheological investigations of gibbsite particles in synthetic bayer liquors. Colloids and surfaces A : physicochemical and engineering aspects, 157(1-3), 137-145.
DOI Scopus22 WoS17
1999 Ralston, J., Prestidge, C. A., & Addai Mensah, J. (1999). Interparticle forces, interfacial structure development and agglomeration of gibbsite particles in synthetic bayer liquors. Minerals engineering, 12(6), 655-669.
DOI Scopus39 WoS31
1999 Harris, D. D., Keir, R., Prestidge, C. A., & Thomas, J. C. (1999). A Dynamic Light Scattering Investigation of Nucleation and Growth in Supersaturated Alkaline Sodium Aluminate Solutions (Synthetic Bayer Liquors). Colloids and surfaces A : physicochemical and engineering aspects, 154(3), 343-352.
DOI
1999 Prestidge, C. A. (1999). Rheological investigations of DLVO and non-DLVO particle interactions in concentrated mineral suspensions. Minerals Processing and Extractive Metallurgy Review.
1999 Thomas, J. C., Prestidge, C. A., Keir, R., & Harris, D. R. (1999). A dynamic light scattering investigation of nucleation and growth in supersaturated alkaline sodium aluminate solutions (synthetic Bayer liquors). Colloids and surfaces A : physicochemical and engineering aspects.
1998 Addai Mensah, J., Dawe, J., Hayes, R. A., Prestidge, C. A., & Ralston, J. (1998). The unusual colloid stability of gibbsite at high pH. Journal of colloid and interface science, 203(1), 115-121.
DOI Scopus44 WoS36
1997 Ralston, J., Prestidge, C. A., & Grano, S. R. (1997). Sulphite modification of galena surfaces and its effect on flotation and xanthate adsorption. International journal of mineral processing, 52(1), 1-29.
DOI Scopus39
1997 Skinner, W. M., Ralston, J., Prestidge, C. A., & Grano, S. R. (1997). Surface modifications in the chalcopyrite-sulphite ion system. II. Dithiophosphate collector adsorption study. International journal of mineral processing, 50(1-2), 27-45.
DOI Scopus41 WoS34
1997 Ralston, J., Prestidge, C. A., & Grano, S. R. (1997). Solution interaction of ethyl xanthate and sulphite and its effect on galena flotation and xanthate adsorption. International journal of mineral processing, 52(2-3), 161-186.
DOI Scopus49
1997 Skinner, W. M., Ralston, J., Prestidge, C. A., Grano, S. R., Crossen, H., & Sollart, M. (1997). Surface modifications in the chalcopyrite-sulphite ion system. I. Collectorless flotation, XPS and dissolution study. International journal of mineral processing, 50(1-2), 1-26.
DOI Scopus56 WoS54
1997 Prestidge, C. A., & Rowlands, W. (1997). Electroacoustic measurements of sulfide mineral particles. Minerals engineering, 10(10), 1107-1118.
DOI
1997 Prestidge, C. A. (1997). Rheological investigations of ultrafine galena particle slurries under flotation-related conditions. International journal of mineral processing, 51(1-4), 241-254.
DOI
1997 Smart, R. S. C., Skinner, W. M., Ralston, J., & Prestidge, C. A. (1997). Copper(II) activation and cyanide deactivation of zinc sulphide under mildly alkaline conditions. Applied surface science, 108(3), 333-344.
DOI Scopus86 WoS74
1997 Prestidge, C. A. (1997). Rheological investigations of galena particle interactions. Colloids and surfaces A : physicochemical and engineering aspects, 126(2-3), 75-83.
DOI
1996 Kim, B. S., Hayes, R. A., Prestidge, C. A., Ralston, J., & Smart, R. S. C. (1996). In-situ scanning tunnelling microscopy studies of galena surfaces under flotation related conditions. Colloids and Surfaces A Physicochemical and Engineering Aspects, 117(1-2), 117-129.
DOI
1996 Prestidge, C. A., & Ralston, J. (1996). Contact angle studies of ethyl xanthate coated galena particles. Journal of Colloid and Interface Science, 184(2), 512-518.
DOI
1996 Prestidge, C. A., & Ralston, J. (1996). Contact angle studies of particulate sulphide minerals. Minerals Engineering, 9(1), 85-102.
DOI
1996 Subrahmanyam, T. V., Prestidge, C. A., & Ralston, J. (1996). Contact angle and surface analysis studies of sphalerite particles. Minerals Engineering, 9(7), 727-741.
DOI
1996 Muster, T. H., Toikka, G., Hayes, R. A., Prestidge, C. A., & Ralston, J. (1996). Interactions between zinc sulphide particles under flotation-related conditions. Colloids and Surfaces A Physicochemical and Engineering Aspects, 106(2-3), 203-211.
DOI
1996 Skinner, W. M., Prestidge, C. A., & Smart, R. S. C. (1996). Irradiation effects during xps studies of Cu(II) activation of zinc sulphide. surface and interface analysis, 24(9), 620-626.
DOI Scopus95 WoS93
1995 Muster, T. H., & Prestidge, C. A. (1995). Rheological investigations of sulphide mineral slurries. Minerals Engineering, 8(12), 1541-1555.
DOI
1995 Prestidge, C. A., Skinner, W. M., Ralston, J., & Smart, R. S. C. (1995). The interaction of iron(III) species with galena surfaces. Colloids and surfaces A: physicochemical and engineering aspects, 105(2-3), 325-339.
DOI Scopus8 WoS4
1995 Kim, B. S., Hayes, R. A., Prestidge, C. A., Ralston, J., & Smart, R. S. C. (1995). Scanning tunnelling microscopy studies of galena: The mechanisims of oxidation in aqueous solution. Langmuir, 11(7), 2554-2562.
1994 Kim, B. S., Hayes, R. A., Prestidge, C. A., Ralston, J., & Smart, R. S. C. (1994). Scanning tunnelling microscopy studies of galena: the mechanism of oxidation in air. Applied Surface Science, 78(4), 385-397.
DOI
1994 Prestidge, C. A., Thiel, A. G., Ralston, J., & Smart, R. S. C. (1994). The interaction of ethyl xanthate with copper (II) activated zinc sulphide: kinetic effects. Colloids and Surfaces A Physicochemical and Engineering Aspects, 85(1), 51-68.
DOI
1993 Prestidge, C. A., Ralston, J., & Smart, R. S. C. (1993). The role of cyanide in the interaction of ethyl xanthate with galena. Colloids and Surfaces A Physicochemical and Engineering Aspects, 81, 103-119.
DOI
1993 Prestidge, C. A., Ralston, J., & Smart, R. S. C. (1993). The competitive adsorption of cyanide and ethyl xanthate on pyrite and pyrrhotite surfaces. International journal of mineral processing, 38(3-4), 205-233.
DOI

Year Citation
2020 Joyce, P., Schultz, H. B., Meola, T. R., & Prestidge, C. A. (2020). Polymer lipid hybrid (PLH) formulations: A synergistic approach to oral delivery of challenging therapeutics. A synergistic approach to oral delivery of challenging therapeutics. In Delivery of Drugs Volume 2 Expectations and Realities of Multifunctional Drug Delivery Systems (pp. 1-27). Elsevier.
DOI Scopus5
2020 Joyce, P., Schultz, H. B., Meola, T. R., & Prestidge, C. A. (2020). Polymer lipid hybrid (PLH) formulations: a synergistic approach to oral delivery of challenging therapeutics. In R. Shegokar (Ed.), Source details - Title: Delivery of Drugs. Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems (pp. 1-27). UK: Elsevier.
DOI
2016 Kempson, I. M., & Prestidge, C. A. (2016). Mass spectrometry imaging of pharmaceuticals: from tablets to tissues. In T. Rades, Y. Perrie, & A. Mullertz (Eds.), Source details - Title: Analytical techniques in the pharmaceutical sciences (pp. 629-647). New York: Springer.
DOI
2014 Krasowska, M., Prestidge, C. A., & Beattie, D. A. (2014). Atomic force microscopy for determining surface interactions of relevance for food foams and emulsions. In Source details - Title: Food texture design and optimization (Vol. 9780470672426, pp. 402-422). UK: Wiley.
DOI Scopus6
2014 Prestidge, C. A., & Barnes, T. J. (2014). Nanoporous silicon to enhance drug solubility. In H. A. Santos (Ed.), Source details - Title: Porous silicon for biomedical applications (pp. 356-373). UK: Woodhead Publishing.
DOI
2012 Kempson, I. M., Hwu, Y., & Prestidge, C. A. (2012). Probing protein association with nano- and micro-scale structures with ToF-SIMS. In T. Horbett, J. L. Brash, & W. Norde (Eds.), Source details - Title: Proteins at interfaces III state of the art - volume 1120 (Vol. 1120, pp. 709-729). US: AMER CHEMICAL SOC.
DOI Scopus1 WoS1
2008 Prestidge, C. A. (2008). From Novel Monodisperse 'Silicone Oil'/Water Emulsions to Drug Delivery. In Source details - Title: New Frontiers in Colloid Science (pp. 70-89). London: RSC Publishing.
DOI
2005 Addai Mensah, J., & Prestidge, C. A. (2005). Structure formation in dispersed systems. In Corporate body:University of South AustraliaSource details - Title: Coagulation and Flocculation Second Edition (2 ed., pp. 135-216). Boca Raton, FL, US: CRC Press, Taylor & Francis Group.
DOI Scopus15
2003 Smart, R. S. C., Amarantidis, J., Skinner, W. M., Prestidge, C. A., La Vanier, L., & Grano, S. R. (2003). Surface analytical studies of oxidation and collector adsorption in sulfide mineral flotation. In K. Wandelt, & S. Thurgate (Eds.), Source details - Title: Solid-liquid interfaces : macroscopic phenomena - microscopic understanding (pp. 3-62). US: Springer.
DOI
1994 Smart, R. S., Arora, P. S., Hayes, R., Kim, B. S., Prestidge, C., & Ralston, J. (1994). Chemical and structural alteration in the surface layers of oxides and sulphides. In Source details - Title: Science of ceramic interfaces II (pp. 311-340). Netherlands: Elsevier.
DOI

Year Citation
2021 Tam, J., Coller, J., Hughes, P., Prestidge, C., & Bowen, J. (2021). Investigation of TLR4 antagonists for prevention of intestinal inflammation. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 113). WILEY.
2015 Pocock, K. J., Gao, X., Wang, C., Priest, C., Prestidge, C., Mawatari, K., . . . Thierry, B. (2015). Low-temperature bonded glass-membrane microfluidic device for in vitro organ-on-a-chip cell culture models. In Proceedings of SPIE - The international society for optical engineering Vol. 9668 (pp. 1-9). US: SPIE - The International Society for Optical Engineering.
DOI Scopus1
2009 Simovic, S., He, H., Song, Y., Peddie, F., Rades, T., Davey, A. K., & Prestidge, C. A. (2009). Spray dried and phase coacervated microcapsules improveing the oral bioabailability of indomethacin. In Teams for tomorrow. Canberra, Australia: APSA.
2009 Bremmell, K. E., Song, Y., Simovic, S., & Prestidge, C. A. (2009). Tabletisation of novel solid dosage forms based on nanoparticle-lipid microcapsules for oral delivery. In PharmSciFair Conference. France: PharmSciFair.
2007 Jarvis, K., Barnes, T. J., & Prestidge, C. A. (2007). The influence of thermal oxidation on the surface chemical and adsorbent properties of porous silicon. In 35th Australasian Chemical Engineering Conference (2007 Chemeca): Conference Proceedings. Australia: Engineers Australia.
2006 Eskandar, N. G., Simovic, S., Saupe, A., Rades, T., & Prestidge, C. A. (2006). The influence of silica nanoparticles on the preparation and stability of O/W emulsions. In C. Jagadish, & G. Q. M. Lu (Eds.), Proceedings of the 2006 International Conference on Nanoscience and Nanotechnology (pp. 142-145). Piscataway: IEEE.
DOI Scopus1 WoS1
2006 Jarvis, K., Barnes, T. J., Prestidge, C. A., Badalyan, A., & Pendleton, P. (2006). Porous silicon : a nanostructured delivery system. In Proceedings of the 2006 International Conference on Nanoscience and Nanotechnology (pp. 536-539). Piscataway, NJ: IEEE.
DOI Scopus2 WoS1
2006 Ghouchi Eskandar, N., Simovic, S., & Prestidge, C. A. (2006). Stability and release of vitamin A in nanoparticle stabilised O/W emulsions. In APSA. Australia: APSA.
2006 Barnes, T. J., Prestidge, C. A., Mierczynska Vasilev, A., Kempson, I. M., & Peddie, F. (2006). Peptide and protein loading into porous silicon wafers. In Chemeca 2006 : knowledge and innovation : conference proceedings (pp. 1019-1023). Auckland, N.Z.: Centre for Continuing Education.
2006 Barnes, T. J., Ametov, I., & Prestidge, C. A. (2006). Dendrimer assembly in solution and at interfaces. In Proceedings of the 2006 International Conference on Nanoscience and Nanotechnology. Piscataway, NJ: IEEE.
DOI
2006 Ametov, I., Barnes, T. J., & Prestidge, C. A. (2006). Atomic force microscopy and dynamic light scattering studies of dendrimer aggregation. In Chemeca 2006 : knowledge and innovation : conference proceedings. Auckland, N.Z.: Centre for Continuing Education.
2005 Barnes, T. J., Er, Y., Tan, A., Prestidge, C. A., & Evans, A. M. (2005). Colloidal stability of lecithin liposomes. In Smart Solutions Doing More with Less, Chemeca 2005: Conference Proceedings. Australia: Institution of Engineers, IChemE, SCENZ and RACI, with University of Queensland.
2005 Prestidge, C. A., & Simovic, S. (2005). Nanoparticle encapsulation of emulsion droplets. In International journal of pharmaceutics Vol. 324 (pp. 92-100). Parma, Italy: Elsevier.
DOI
2005 Ametov, I., Bremmell, K. E., & Prestidge, C. A. (2005). Correlation of bulk rheology of human blood with nano-rheology and deformability of individual erythrocytes. In Smart Solutions Doing More with Less, Chemeca 2005: Conference Proceedings. Australia: Institution of Engineers, IChemE, SCENZ and RACI, with University of Queensland.
2005 Barnes, T. J., Er, Y., Prestidge, C. A., & Fornasiero, D. (2005). Role of PEG-lipids on the controlled release of a model hydrophilic drug from liposomes. In Smart Solutions Doing More with Less, Chemeca 2005: Conference Proceedings. Australia: Institution of Engineers, IChemE, SCENZ and RACI, with University of Queensland.
2004 Simovic, S., & Prestidge, C. A. (2004). Nanoparticles at the emulsion droplet-water interface. In 24th Australian Colloid and Surface Science Student Conference. Australia.
2003 Addai Mensah, J., Li, J., & Prestidge, C. A. (2003). Gibbsite crystallization from caustic aluminate liquors : the influence of solution species and structure on the crystallization behaviour. In Proceedings of the 31st Australasian Chemical Engineering Conference : Chemeca 2003 Proceedings. Adelaide: University of Adelaide.
2003 Ametov, I., Prestidge, C. A., & Barnes, T. J. (2003). Rheological investigations of emulsion stability. In CHEMECA 2003: Products and Processes for the 21st Century. Australia.
2002 Simovic, S., & Prestidge, C. A. (2002). Nanoparticle adsorption at the emulsion droplet-water interface. In 23rd Australian Colloid and Surface Science Student Conference. Australia.
2002 Prestidge, C. A., Gillies, G. S., & Attard, P. J. (2002). Interaction forces, deformation and nano-rheology of cross-linked PDMS droplets as determined by colloid probe AFM. In 3rd World Emulsion Congress. Lyon, France.
2002 Prestidge, C. A., & Simovic, S. (2002). Nanoparticle adsorption at the PDMS droplet-water interface. In 3rd World Emulsion Congress. Lyon, France.
2001 Muster, T. H., & Prestidge, C. A. (2001). Face Specific Surface Properties of Pharmaceutical Crystals. In Proceedings of the Australasian Pharmaceutical Science Association Annual Conference 2001.
2001 Muster, T. H., & Prestidge, C. A. (2001). Face Dependent Properties of Pharmaceutical Crystals. In Particles 2001, Orlando, Florida.
2001 Gillies, G. S., Prestidge, C. A., & Attard, P. J. (2001). Atomic Force Microscopy of Viscoelastic Particles: Theory and Measurement. In Australian Colloid and Surface Science Symposium.
2000 Prestidge, C. A., & Barnes, T. J. (2000). The deformability and interaction of PDMS emulsion droplets in water. In 10th International Conference on Colloid and Interface Science.
2000 Verity, B., Ralston, J., Prestidge, C. A., Morey, M. S., & Grano, S. R. (2000). The electrochemistry of Pb(II) activated sphalerite in relation to flotation. In Flotation 2000.
2000 Ralston, J., Prestidge, C. A., & Grano, S. R. (2000). The adsorption of dicresyl dithiophosphate onto pyrite, I. A UV-visible spectroscopic study of adsorption kinetics. In Electrochemistry in Mineral and Metal Processing. New Jersey: The Electrochemical Society.
2000 Prestidge, C. A., & Muster, T. H. (2000). Crystal face dependent properties of sulfathiazole: Surface chemistry, roughness, wettability and adhesion. In 10th International Conference on Colloid and Interface Science.
2000 Ralston, J., Prestidge, C. A., & Bandini, P. (2000). Colloidal iron oxide slime coatings and galena particle flotation. In Flotation 2000.
1999 Ralston, J., Prestidge, C. A., Ametov, I., & Addai Mensah, J. (1999). Particle interactions and surface forces during gibbsite precipitation from bayer liquors. In Fifth International Alumina Qaulity Workship.
1998 Tsatouhas, G., Prestidge, C. A., & Hayes, D. (1998). Rheology and atomisation of ethyl cellulose solutions. In N. Nguyen, Q. D. Huilgol, & R. R. R.R. (Eds.), Proceedings of 8th Australian Conference on Rheology. Adelaide, Australia: Australian Society of Rheology.
1998 Prestidge, C. A., & Ametov, I. (1998). Gibbsite particle interactions under bayer processing conditions: A rheological study. In N. Nguyen, Q. D. Huilgol, & R. R. R.R. (Eds.), Proceedings of 8th Australian Conference on Rheology. Adelaide, Australia: Australian Society of Rheology.
1998 Ralston, J., Prestidge, C. A., Gerson, A. R., Ametov, I., & Addai Mensah, J. (1998). Interactions between gibbsite crystals in supersaturated caustic aluminate solutions. In B. J. Welch (Ed.), Light Metals (pp. 159-166). USA: MINERALS, METALS & MATERIALS SOC.
Scopus13 WoS14

Year Citation
2016 Prestidge, C. A., & Joyce, P. M. (2016). WO2016141413A1, Drug delivery composition comprising polymer-lipid hybrid microparticles.
2009 Prestidge, C., & Simovic, S. (2009). US20090263486, Nanoparticle-stabilized capsule formulation for treatment of inflammation.
2007 Prestidge, C., Simovic, S., & Ghouchi Eskandar, N. (2007). WO2007128066, Drug release from nanoparticle-coated capsules.
2006 Prestidge, C. A., & Simovic, S. (2006). AU2006255477, Dried formulations of nanoparticle-coated capsules.

  • Omega-3 Fatty Acid Quantification in Patient Plasma Samples, Pharmako Biotechnologies Pty Ltd, 15/10/2024 - 27/08/2025

  • Formulation and characterisation of lipid prodrug, OyaGen Inc, 01/07/2025 - 14/07/2025

  • Maximising the antimicrobial and anti-inflammatory performance of next generation therapeutics for Chronic Rhinosinusitis, NHMRC - Project Grant, 01/01/2019 - 31/12/2021

  • ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC - Centre of Excellence, 01/04/2014 - 29/06/2021

  • Optimization and validation of assay of French protocol for phenotyping patient samples for treatment optimization, Pari-Passou Medical Consultancy, 03/08/2020 - 31/12/2020

  • Mechanistic insight into Pharmako's Oral Curcumin Product: LipiSperse®, Pharmako Biotechnologies Pty Ltd, 03/10/2018 - 25/12/2019

  • Targeting particulate carriers to epithelial M cells, ARC - Linkage Project, 15/12/2015 - 30/09/2019

  • Targeting Particulate Carriers to Epithelial M Cells, CeramiSphere Pty Ltd, 01/01/2016 - 30/06/2019

  • Research Infrastructure Fund (RIF) Grant 2016 Round 2 - Biofilm Testing Facility, Adelaide Integrated Bioscience Laboratories, 28/11/2016 - 31/12/2017

  • Lipoceramic reformulation of simvastatin, Reformpharm Pty Ltd, 23/11/2016 - 31/12/2017

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Nicole Chan
2024 Co-Supervisor - - Master Full Time Mr Alex Hunter
2024 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Mr Ali Taheri
2024 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Simone Kelly Babij
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Ms Zarnab Asif
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Srinivas Kamath
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Yukta Hegishte
2023 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Miss Thi My Hanh Tran
2023 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Miss Isabella Ampelia Revesz
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Amer Moh'd Mah'd Abdelhafez
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Amin Ariaee
2022 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Anam Ahsan
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Nikita Parekh
2022 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Miss Stephanie Stodulka
2021 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Mrs Ruba Jawad Abdulrahman Almasri
2021 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Ms Mitra Hosseini Kharat

Date Role Research Topic Program Degree Type Student Load Student Name
2018 - 2022 External Supervisor Exploring the Effects of Toll-Like Receptor 4 Antagonism on Gastrointestinal Mucositis and Tumour Activity Doctor of Philosophy Doctorate Full Time Miss Shu Yie Janine Tam
2014 - 2017 External Supervisor Towards Novel Antibiofilm Strategies Doctor of Philosophy Doctorate Full Time APrf Katharina Richter
2012 - 2012 External Supervisor Epigenetics in Cancer: Basic and Translational Aspects Doctor of Philosophy Doctorate Full Time Ms Sue Lim

Connect With Me

External Profiles

Other Links